Allstate is taking on a group of New York pharmacies and wholesalers, claiming they pulled off a $1.48 million scam against its no-fault auto insurance program.
Filed on August 13, 2025, in the US District Court for the Eastern District of New York, the lawsuit puts the spotlight on Cypress Rx Inc. and a long list of related pharmacies, wholesalers, and individuals. Allstate says these businesses and their owners worked together to submit bogus claims for reimbursement under New York’s No-Fault insurance laws, all at the insurer’s expense.
According to Allstate’s complaint, the pharmacies and their partners didn’t just fudge a few numbers. The insurer claims they hid the real story about which drugs and services were actually eligible for reimbursement under state law. Allstate says it ended up paying for drugs that shouldn’t have been covered, at prices that were too high, and that some of the medications were dispensed in violation of regulatory and licensing requirements. There’s also an accusation that some of the defendants maintained relationships with prescribers, allegedly inducing them to furnish prescriptions for medically unnecessary drugs.
Allstate says it relied on what these pharmacies told them, and as a result, paid out more than $1.48 million in claims that it now believes were fraudulent. The complaint lists out the payments, including over $129,600 to Cypress Rx Inc., more than $76,000 to Briar Drug Store Inc. d/b/a Briarwood Rx, and upwards of $231,000 to Better Soon Rx Inc. The total, Allstate claims, is more than $1,480,700, all tied to what it calls fraudulent and non-compensable claims.
The insurer isn’t just asking for its money back. It wants the court to declare that Cypress Rx Inc. has no standing to seek, collect, or retain any payments made by Allstate in connection with assigned No-Fault benefits, and that Allstate has no legal obligation to pay any unpaid or pending bills submitted by Cypress Rx Inc. Allstate is also seeking compensatory and treble damages, as well as an injunction to prevent the defendants from engaging in the alleged conduct.
The complaint is based on Allstate’s claims and allegations, and the case is still in its early stages. No final judgment or settlement has been reached, and the damages Allstate is seeking will be determined at trial.
For insurance professionals, this case is a reminder of the risks and complexities of No-Fault claims. Fraud, compliance, and the importance of careful claims review are all in play. As the lawsuit moves forward, it’s one to watch for those in the business of handling claims or investigating fraud. The outcome could have implications for how similar cases are handled in the future.
